Now showing items 1-6 of 6
Stopping the overmedication of people with intellectual disability, autism or both (STOMP) and supporting treatment and appropriate medication in paediatrics (STAMP)
(Royal College of Psychiatrists, 2021-08-15)
Valproate prescribing practices for women with intellectual disability across Europe.
BACKGROUND: Valproate (VPA) is a known teratogen associated with greater risk of major congenital malformations and other neurodevelopmental sequelae than all other licensed antiepileptic medicines. To reduce the potential ...
UK psychiatrists' experience of withdrawal of antipsychotics prescribed for challenging behaviours in adults with intellectual disabilities and/or autism.
BACKGROUND: A high proportion of adults with intellectual disabilities are prescribed off-licence antipsychotics in the absence of a psychiatric illness. The National Health Service in England launched an initiative in ...
Attention deficit hyperactivity disorder (ADHD) in adults with intellectual disability
(Royal College of Psychiatrists, 2021-02-01)
The field of neurodevelopmental disorders is an exciting one in clinical practice. People with intellectual disability are more likely to have associated neurodevelopmental disorders such as autism and attention hyperactivity ...
Mental health services for adults with mild intellectual disability
(Royal College of Psychiatrists, 2020-03-01)
Meeting the mental health needs of people with mild intellectual disability (ID) can be a challenge to all mental health services. Not everyone with ID will be eligible to receive specialist ID services and therefore they ...
Patterns of comorbidity and psychopharmacology in adults with intellectual disability and attention deficit hyperactivity disorder: an UK national cross-sectional audit.
Background: Attention-deficit hyperactivity disorder (ADHD) is higher in people with intellectual disability (ID) compared to the general population. Available limited evidence suggests this population has increased ...